Medidata Solutions Shares Outstanding 2009-2018 | MDSO

Medidata Solutions shares outstanding from 2009 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Medidata Solutions Annual Shares Outstanding
(Millions of Shares)
2017 60
2016 57
2015 57
2014 55
2013 54
2012 51
2011 49
2010 48
2009 41
2008 14
2007 13
Medidata Solutions Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 62
Q2 2018 61
Q1 2018 60
Q4 2017 60
Q3 2017 61
Q2 2017 60
Q1 2017 58
Q4 2016 57
Q3 2016 58
Q2 2016 57
Q1 2016 57
Q4 2015 57
Q3 2015 57
Q2 2015 56
Q1 2015 56
Q4 2014 55
Q3 2014 55
Q2 2014 55
Q1 2014 52
Q4 2013 54
Q3 2013 54
Q2 2013 53
Q1 2013 53
Q4 2012 51
Q3 2012 51
Q2 2012 51
Q1 2012 50
Q4 2011 49
Q3 2011 49
Q2 2011 50
Q1 2011 50
Q4 2010 48
Q3 2010 48
Q2 2010 47
Q1 2010 47
Q4 2009 41
Q3 2009 48
Q2 2009 36
Q1 2009 35
Q4 2008 0
Q3 2008 14
Q2 2008 14
Sector Industry Market Cap Revenue
Medical Medical Information Systems $4.433B $0.546B
Medidata Solutions is a leading global provider of hosted clinical development solutions that enhance the efficiency of customers' clinical development processes and optimize their research and development investments. Medidata products and services allow customers to achieve clinical results more efficiently and effectively by streamlining the design, planning and management of key aspects of the clinical development process, including protocol development (Medidata Designer), investigator benchmarking and budgeting (Medidata Grants Manager), contract research organization (CRO) benchmarking and budgeting (Medidata CRO Contractor), and the capture, management, analysis and reporting of clinical trial data (Medidata Rave). Medidata's diverse customer base spans pharmaceutical, biotechnology and medical device companies, academic institutions, CROs and other research organizations, and includes some top global pharmaceutical companies.
Stock Name Country Market Cap PE Ratio
Cerner (CERN) United States $19.074B 26.68
Athenahealth (ATHN) United States $5.336B 36.40
HMS Holdings Corp (HMSY) United States $3.121B 48.30
Omnicell (OMCL) United States $2.886B 63.88
IRHYTHM TECH (IRTC) United States $1.796B 0.00
Allscripts Healthcare Solutions (MDRX) United States $1.793B 20.12
Tabula Rasa Healthcare (TRHC) United States $1.362B 190.20
Quality Systems (NXGN) United States $1.025B 30.48
Invitae (NVTA) United States $0.988B 0.00
Inspire Medical Systems (INSP) $0.970B 0.00
111 Sponsored ADR (YI) China $0.817B 0.00
AXONICS MODULTN (AXNX) United States $0.401B 0.00
Computer Programs And Systems (CPSI) United States $0.359B 14.47
NantHealth (NH) United States $0.150B 0.00
Strata Skin Sciences (SSKN) United States $0.078B 0.00
FULGENT GENETIC (FLGT) United States $0.060B 0.00
Motus GI Holdings (MOTS) United States $0.053B 0.00
Digirad (DRAD) United States $0.021B 0.00
Streamline Health Solutions (STRM) United States $0.018B 0.00
Transgenomic (PRPO) United States $0.007B 0.00